Related Experiment Video
Updated: May 23, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Immunotherapy as rescue for cardiomyopathy in Omenn syndrome
Simon Boutinaud1, Vincent Barlogis2, Lionel Berthomieu3
1Department of Pediatric Immunology, CHU Toulouse, Toulouse, France.
Abstract:
A 6-month-old infant with Omenn syndrome and severe hypertrophic cardiomyopathy showed significant clinical improvement following multimodal immunosuppression with anti-IL-5 and alemtuzumab. This targeted approach successfully stabilized the patient, providing a critical bridge to curative hematopoietic stem cell transplantation.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
